Skip to main content
Air Liquide
Air Liquide worldwide
Please select

Engineering & Construction

Open

Large projects

Open

Air Liquide Japan agreed on joint sales promotion for hand disinfection products

Air Liquide Japan Ltd. has agreed with Kyorin Pharmaceutical Company, Limited (head-office: Chiyoda-Ku, Tokyo, President: Mitsutomo Miyashita), which is a subsidiary of Kyorin Holdings, Inc (head-office: Chiyoda-Ku, Tokyo, President: Minoru Hogawa) upon their partnership in sales promotion and supply for Air Liquide Japan’s hygiene product group, specialized in hand antisepsis. This partnership will become effective in around spring 2017.

The hand hygiene product group covered in this agreement include alcohol hand hygiene agents, named “Puremist®” and “Purerubbing®”, antimicrobial soap, “Microshield®”, hand soap and lotion, “Gentle Cleanser” and “Lotion Moisturizer,” which are used for infection control at hospitals and medical institutions. Since Schulke & Mayr GmbH, Air Liquide’s entity specialized in hygiene and nosocomial-infection-related products, acquired the Japanese business in December 2015, Air Liquide Japan has been engaged into the sales expansion of the products in Japan.

Kyorin Pharmaceutical Group has been devoted to its environmental hygiene business to contribute, via the control over environmental infection, to meeting the medical needs for health amid the growing importance on daily preventive control of infection at medical institutions in Japan. Entering into the partnership with Air Liquide Japan, Kyorin shall aim even further at expanding its product portfolio.

Serving also as a provider of medical gases, equipment and services in the healthcare field, Air Liquide Japan has firmly built its presence in healthcare field inside Japan. By utilizing the wide-ranging network of pharmaceutical and medical business operations developed by Kyorin, Air Liquide Japan shall further develop its support structure and sales network to respond quickly to its customer needs and thereby reinforce its business.

Shiro Yahara, President of Air Liquide Japan, commented, “Making the partnership with Kyorin Pharmaceutical Company and jointly marketing this product group, we are convinced that our Company will reach the market more broadly and deeply. To unequivocally demonstrate our policy, “Customer First,” we will improve further on our corporate and service structure to precisely meet customers’ demands in the healthcare field.”

 

Air Liquide in Japan
Established in 1907 in Japan,  Air Liquide now serves 15,000 customers across the country, particularly in Electronics, thanks to its 2,000 employees. The Group also has a Research and Technology Centre in Tsukuba (near Tokyo) and an Engineering center in  Kobe. Japan serves as a technology & research base for Air Liquide in Asia and beyond.

Schülke in brief
Subsidiary of the Air Liquide group within the Healthcare activity and expert in hospital disinfection, Schülke designs and supplies since more than 125 years a wide range of disinfectants and antiseptics mainly destined for medical environment to actively contribute to patient safety. Present in 80 countries through its affiliates and network of distributors, Schülke employs over 900 people around the world, including 70 researchers. www.schuelke.com

Air Liquide Healthcare*
Supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients. In 2015, it served over 7,500 hospitals and more than 1.3 million patients at home throughout the world. The Group’s Healthcare business reached € 2,799 million in revenues in 2015, with the support of its 13,500 employees. Home healthcare represents 50% of Air Liquide's revenue in Healthcare in 2015.
*These data do not include Airgas, whose acquisition was completed on May 23, 2016.

Kyorin Pharmaceutical Company
Kyorin Pharmaceutical Group aims to evolve  itself to a sustainably growing company supporting people’s healthy lives, based on its long term vision “HOPE 100”, by focusing on pharmaceutical business, combined with other healthcare businesses. At the 2nd stage of  “HOPE 100”, it intends for growth in environmental hygiene business, synergy with existing businesses, under the growth strategy, “to pool the next core business pipelines by developing one key business pillar in healthcare business”.


CONTACTS
Air Liquide Japan Communications
Shun Toyoyama
03 6414 6728

 

Download the document